Dr. Naira Baregamian, MD, MMSC

  • Nashville, TN
  • Surgical oncologist
NPI1144411323
Medicare services, 2024
129
Medicare patients, 2024
68
Part D claims, 2024
13
Publications
41
Clinical trials
2
Practice address
1211 Medical Center Drive, Nashville, TN 37232
Practice phone
Call (615) 322-3454
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Vanderbilt University Medical Center

Hospital · Nashville, Tennessee

See all 3 affiliations

Find Dr. Baregamian's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Naira Baregamian is a surgical oncologist in Nashville, Tennessee

Dr. Baregamian practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Baregamian's NPI, 1144411323, was assigned on August 5, 2007. Dr. Baregamian graduated from St. George's University School of Medicine in 2003. Dr. Baregamian holds Tennessee license 51740.

NPI and contact details
NPI enumeration date
August 5, 2007
NPI status
Active
Practice phone
(615) 322-3454
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
49
Medical school graduation
2003

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data

Dr. Naira Baregamian practices at Vanderbilt University Medical Center in Nashville, Tennessee

Dr. Baregamian's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Source: Dmand AI Affiliation Data

Dr. Naira Baregamian is affiliated with 2 sites of care and 1 medical group

Dr. Baregamian's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Baregamian to 1 more group practice or clinic, named with a free account.

See all 3 affiliations for Dr. Baregamian

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Naira Baregamian's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baregamian practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Vanderbilt University Medical CenterAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Baregamian practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Vanderbilt University Medical Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Naira Baregamian is one of 56 surgical oncologists in Tennessee

Surgical oncology is Dr. Baregamian's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Baregamian is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Baregamian's licenses on file in 5 states: Tennessee, California, Connecticut, Alabama and Ohio.

Specialties and state licenses

  • Surgical oncology, TennesseePrimaryLicense MD51740 · 2014 to 2026 · taxonomy 2086X0206X
  • California licenseSince 2011
  • Connecticut license2013 to 2021
  • Alabama license2020
  • Ohio license2011 to 2013

Clinical focus

Dmand AI lists thyroid surgery among the conditions Dr. Baregamian treats.

Surgical oncologists near Dr. Baregamian

Counts of surgical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Naira Baregamian billed Medicare for 129 services in 2024

CMS data shows 129 Medicare services from Dr. Baregamian across 4 procedure codes in 2024, for 68 Medicare patients. Medicare paid $29,726 for them.

Medicare services, 2024129
Medicare patients68
Paid by Medicare$29,726
Procedure codes4

Dr. Baregamian's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 492024: 6839%
Surgery
2023: 152024: 61307%

Where Dr. Baregamian's Medicare services took place, 2024

  • In an office6853%
  • In a facility6147%

Dr. Baregamian compared with the Tennessee median for surgical oncologists, 2024

  • Dr. Baregamian
  • Tennessee median
Medicare services
129vs 1387% below
Medicare patients
68vs 8823% below
Part D claims
11vs 2658% below

Medians across 51 surgical oncologists in Tennessee with Dmand AI profiles that report each measure.

Dr. Baregamian's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Baregamian

Need commercial claims for Dr. Baregamian?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Baregamian and other surgical oncologists in Tennessee.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Naira Baregamian treated 68 Medicare patients in 2024, average age 69

CMS counts 68 Medicare patients who saw Dr. Baregamian in 2024. The largest group is 65 to 74, with 43 patients. 74% of them have high blood pressure, and 69% have high cholesterol. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Baregamian's median patient age at 58, with 52% women.

Medicare patients, 202468
Average age69
Average risk score1.28

Dr. Baregamian's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Baregamian's Medicare patients by sex, 2024

  • Women5276%
  • Men1624%

Chronic conditions among Dr. Baregamian's Medicare patients, 2024

  1. High blood pressure74%
  2. High cholesterol69%
  3. Arthritis41%
  4. Osteoporosis34%
  5. Chronic kidney disease31%
  6. Diabetes29%
  7. Anxiety28%
  8. Ischemic heart disease24%

Share of Medicare patients with each condition. A patient can have several.

Dr. Baregamian's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 58

Patient panel by sex, all payers

  • Women52%
  • Men48%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Naira Baregamian wrote 13 Medicare Part D claims in 2024

In 2024, Dr. Baregamian wrote 13 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $95 in total drug cost. In 2019, CMS named 12 claims across 1 drug.

Part D claims, 202413
Drugs named by CMS1
Total drug cost$95

Dr. Baregamian's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2019 to 2024

  • 2019
  • 2024
Claims for drugs CMS names
2019: 122024: 118%

Drugs named by CMS: 1 in 2024, 1 in 2019.

See all prescribing by Dr. Baregamian

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

For MedTech and pharma teams

Find surgical oncologists like Dr. Baregamian by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Naira Baregamian has 41 publications on record

Dmand AI links 41 papers to Dr. Baregamian, published from 2006 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Parathyroid Glands, Parathyroidectomy and Thyroid Neoplasms. Dr. Baregamian has published most often in Surgery. Dr. Baregamian's most frequent co-authors are Dai H. Chung, MD, Lindsay A. Bischoff, MD and Jennifer H. Choe, MD, PhD.

Papers41
Years published2006 to 2025

Dr. Baregamian's papers by year, 2012 to 2025

Topics Dr. Baregamian writes about most

  • Parathyroid Glands
  • Parathyroidectomy
  • Thyroid Neoplasms
  • Thyroidectomy
  • Thyroid Gland
  • Intestinal Mucosa
  • Optical Imaging
  • Apoptosis

Dr. Baregamian's most frequent co-authors

Recent publications by Dr. Baregamian

See all 41 publications and co-authors

See who Dr. Baregamian researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Baregamian works with, so you can find a warm path to the right surgical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Naira Baregamian has worked on 2 clinical trials

Dmand AI links Dr. Baregamian to 2 clinical trials. Conditions studied include Hypercalcemia, Thyroid Neoplasms and Parathyroid Neoplasms. Vanderbilt-Ingram Cancer Center sponsors the most, 2.

Conditions in Dr. Baregamian's trials

  • Hypercalcemia
  • Thyroid Neoplasms
  • Parathyroid Neoplasms
  • Thyroid Diseases

Investigators on the most trials with Dr. Baregamian

Recent clinical trials with Dr. Baregamian

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Naira Baregamian received $259 in industry payments from 2016 to 2024

CMS Open Payments shows 6 general payments to Dr. Baregamian from 3 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Medtronic USA, Inc. paid the most, $122.

General payments to Dr. Baregamian by program year, 2016 to 2024

Companies that paid Dr. Baregamian the most, 2016 to 2024

Share is of all general payments to this clinician.

See all payments to Dr. Baregamian

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Naira Baregamian graduated from St. George's University School of Medicine

Dr. Baregamian graduated from St. George's University School of Medicine in 2003. Dr. Baregamian is a member of AACE, ACS and ATA.

  1. Medical schoolSt. George's University School of Medicine
  2. Board certified in surgeryAmerican Board of Surgery

Source: Dmand AI Professional Profile Data

Dr. Naira Baregamian accepts plans from 10 insurance carriers

Dr. Baregamian is in network with 10 carriers, including Excellus BlueCross BlueShield, Cigna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.

  • Excellus BlueCross BlueShield
  • Cigna
  • Blue Cross Blue Shield of Michigan
  • HCSC
  • Humana
  • United Healthcare
  • Alliant Health Plans
  • CMS Medicare
  • +2 more carriersWith a free account

Plan types Dr. Baregamian accepts, by number of carriers

  1. Medicare6
  2. PPO6
  3. HMO4
  4. POS3
  5. EPO2
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Naira Baregamian's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Naira Baregamian

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Naira Baregamian's NPI number?

Dr. Naira Baregamian's NPI number is 1144411323. It was assigned on August 5, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Naira Baregamian?

Dr. Naira Baregamian is a surgical oncologist in Nashville, Tennessee. The primary specialty in the NPI Registry is Surgical Oncology Physician (taxonomy code 2086X0206X).

Where does Dr. Naira Baregamian practice?

Dr. Baregamian practices at 1211 Medical Center Drive, Nashville, TN 37232. Dr. Baregamian's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Dmand AI also links Dr. Baregamian to 1 group practice or clinic.

What is Dr. Naira Baregamian's office phone number?

The practice phone on file for Dr. Baregamian is (615) 322-3454.

What is Dr. Naira Baregamian's medical license number?

Dr. Baregamian holds Tennessee license 51740, one of the licenses on file in 5 states.

Which states has Dr. Naira Baregamian been licensed in?

Dmand AI has state licenses on file for Dr. Baregamian in Tennessee (2014 to 2026), California (since 2011), Connecticut (2013 to 2021), Alabama (2020) and Ohio (2011 to 2013).

Which hospitals is Dr. Naira Baregamian affiliated with?

Dr. Baregamian practices at Vanderbilt University Medical Center in Nashville, Tennessee.

What medical group is Dr. Naira Baregamian part of?

Dr. Baregamian is linked to Vanderbilt University Medical Center.

Does Dr. Naira Baregamian accept Medicare?

Yes. CMS data shows Dr. Baregamian billed Medicare for 129 services in 2024.

How many Medicare patients does Dr. Naira Baregamian see?

CMS counts 68 Medicare patients who saw Dr. Baregamian in 2024, with an average age of 69.

Show 9 more questionsShow fewer questions

Is Dr. Naira Baregamian board certified?

Yes. Dr. Baregamian is board certified in surgery by the American Board of Surgery.

What services does Dr. Naira Baregamian bill to Medicare?

In 2024, Dr. Baregamian's most billed Medicare services were office visit, new patient (99205), surgery: heart and blood vessels (36500) and surgery: endocrine glands (60500).

Where did Dr. Naira Baregamian go to medical school?

Dr. Baregamian graduated from St. George's University School of Medicine in 2003.

What drugs does Dr. Naira Baregamian prescribe most?

In 2024 Medicare Part D data, Dr. Baregamian's most prescribed drugs by claims were Calcitriol.

Has Dr. Naira Baregamian received payments from drug or device companies?

CMS Open Payments shows $259 in general payments to Dr. Baregamian from 3 companies from 2016 to 2024. The largest total came from Medtronic USA, Inc.

How long has Dr. Naira Baregamian been practicing?

Dr. Baregamian graduated from medical school in 2003, 23 years ago.

Does Dr. Naira Baregamian do research?

Dmand AI links 41 publications to Dr. Baregamian, published from 2006 to 2025. Dr. Baregamian has worked on 2 clinical trials.

Who does Dr. Naira Baregamian publish with?

Dr. Baregamian's most frequent co-authors are Dai H. Chung, MD (5 shared papers), Lindsay A. Bischoff, MD (4 shared papers) and Jennifer H. Choe, MD, PhD (4 shared papers).

What insurance does Dr. Naira Baregamian accept?

Dr. Baregamian is in network with 10 carriers, including Excellus BlueCross BlueShield, Cigna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.

Selling to surgical oncology practices?

See surgical oncologists in Tennessee by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)